دورية أكاديمية
أعرض في EDS

SUMOylation controls Hu antigen R posttranscriptional activity in liver cancer.

التفاصيل البيبلوغرافية
العنوان: SUMOylation controls Hu antigen R posttranscriptional activity in liver cancer.
المؤلفون: Lachiondo-Ortega S; Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain., Rejano-Gordillo CM; Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain; Department of Biochemistry and Molecular Biology, Faculty of Sciences, University of Extremadura, University Institute of Biosanitary Research of Extremadura (INUBE), 06071 Badajoz, Spain; Biofisika Institute, Consejo Superior de Investigaciones Científicas (CSIC), Departamento Bioquímica y Biología Molecular, Facultad de Ciencia y Tecnología, Universidad del País Vasco (UPV/EHU), Leioa, Spain., Simon J; Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III National Health Institute, Madrid, Spain., Lopitz-Otsoa F; Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain., C Delgado T; Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain., Mazan-Mamczarz K; Laboratory of Genetics and Genomics, National Institute on Aging (NIA), Intramural Research Program (IRP), National Institutes of Health (NIH), Baltimore, MD, USA., Goikoetxea-Usandizaga N; Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain., Zapata-Pavas LE; Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain., García-Del Río A; Cancer Immunology and Immunotherapy Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain., Guerra P; Unit of Internal Medicine and Hepatology (UIMH), Department of Medicine (DIMED), University of Padova, 35128 Padua, Italy., Peña-Sanfélix P; Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain., Hermán-Sánchez N; Maimónides Institute of Biomedical Research of Córdoba (IMIBIC), Department of Cell Biology, Physiology and Immunology of University of Córdoba, Reina Sofia University Hospital, CIBER Pathophysiology of Obesity and Nutrition (CIBERobn), 14004 Córdoba, Spain., Al-Abdulla R; Instituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria de Elche (IDiBE), Universidad Miguel Hernández, Elche, Spain; Institute of Medical Biochemistry and Molecular Biology, University Medicine of Greifswald, 17475 Greifswald, Germany., Fernandez-Rodríguez C; Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain., Azkargorta M; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III National Health Institute, Madrid, Spain; Proteomics Platform, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Carlos III Networked Proteomics Platform (ProteoRed-ISCIII), 48160 Derio, Bizkaia, Spain., Velázquez-Cruz A; Instituto de Investigaciones Químicas (IIQ), Centro de Investigaciones Científicas Isla de la Cartuja (cicCartuja), Universidad de Sevilla, Consejo Superior de Investigaciones Científicas (CSIC), Sevilla, Spain., Guyon J; University of Bordeaux, INSERM, BPH, U1219, 33000 Bordeaux, France; CHU de Bordeaux, Service de Pharmacologie Médicale, 33000 Bordeaux, France., Martín C; Biofisika Institute, Consejo Superior de Investigaciones Científicas (CSIC), Departamento Bioquímica y Biología Molecular, Facultad de Ciencia y Tecnología, Universidad del País Vasco (UPV/EHU), Leioa, Spain., Zalamea JD; Structure and Cell Biology of Viruses Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain., Egia-Mendikute L; Cancer Immunology and Immunotherapy Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain., Sanz-Parra A; Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain., Serrano-Maciá M; Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain., González-Recio I; Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain., Gonzalez-Lopez M; Genome Analysis Platform, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain., Martínez-Cruz LA; Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain., Pontisso P; Unit of Internal Medicine and Hepatology (UIMH), Department of Medicine (DIMED), University of Padova, 35128 Padua, Italy., Aransay AM; Genome Analysis Platform, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain., Barrio R; Ubiquitin-likes and Development Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain., Sutherland JD; Ubiquitin-likes and Development Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain., Abrescia NGA; Structure and Cell Biology of Viruses Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain; Ikerbasque, Basque Foundation for Science, Bilbao, Spain., Elortza F; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III National Health Institute, Madrid, Spain; Proteomics Platform, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Carlos III Networked Proteomics Platform (ProteoRed-ISCIII), 48160 Derio, Bizkaia, Spain., Lujambio A; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Graduate School of Biomedical Sciences at Icahn School of Medicine at Mount Sinai, New York, NY, USA., Banales JM; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III National Health Institute, Madrid, Spain; Ikerbasque, Basque Foundation for Science, Bilbao, Spain; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, San Sebastian, Spain; Department of Biochemistry and Genetics, School of Sciences, University of Navarra, Pamplona, Spain., Luque RM; Maimónides Institute of Biomedical Research of Córdoba (IMIBIC), Department of Cell Biology, Physiology and Immunology of University of Córdoba, Reina Sofia University Hospital, CIBER Pathophysiology of Obesity and Nutrition (CIBERobn), 14004 Córdoba, Spain., Gahete MD; Maimónides Institute of Biomedical Research of Córdoba (IMIBIC), Department of Cell Biology, Physiology and Immunology of University of Córdoba, Reina Sofia University Hospital, CIBER Pathophysiology of Obesity and Nutrition (CIBERobn), 14004 Córdoba, Spain., Palazón A; Cancer Immunology and Immunotherapy Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain; Ikerbasque, Basque Foundation for Science, Bilbao, Spain., Avila MA; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III National Health Institute, Madrid, Spain; Hepatology Program, Centro de Investigación Médica Aplicada (CIMA), University of Navarra, Pamplona, Spain; Instituto de Investigaciones Sanitarias de Navarra (IdiSNA), Pamplona, Spain., G Marin JJ; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III National Health Institute, Madrid, Spain; Experimental Hepatology and Drug Targeting (HEVEPHARM), Instituto de Investigación Biomédica de Salamanca (IBSAL), University of Salamanca, Salamanca, Spain., De S; Laboratory of Genetics and Genomics, National Institute on Aging (NIA), Intramural Research Program (IRP), National Institutes of Health (NIH), Baltimore, MD, USA., Daubon T; University of Bordeaux, CNRS, IBGC, UMR 5095, Bordeaux, France., Díaz-Quintana A; Instituto de Investigaciones Químicas (IIQ), Centro de Investigaciones Científicas Isla de la Cartuja (cicCartuja), Universidad de Sevilla, Consejo Superior de Investigaciones Científicas (CSIC), Sevilla, Spain., Díaz-Moreno I; Instituto de Investigaciones Químicas (IIQ), Centro de Investigaciones Científicas Isla de la Cartuja (cicCartuja), Universidad de Sevilla, Consejo Superior de Investigaciones Científicas (CSIC), Sevilla, Spain., Gorospe M; Laboratory of Genetics and Genomics, National Institute on Aging (NIA), Intramural Research Program (IRP), National Institutes of Health (NIH), Baltimore, MD, USA., Rodríguez MS; Laboratoire de Chimie de Coordination (LCC), UPR 8241, CNRS; IPBS-University of Toulouse III-Paul Sabatier, Toulouse, France., Martínez-Chantar ML; Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III National Health Institute, Madrid, Spain. Electronic address: mlmartinez@cicbiogune.es.
المصدر: Cell reports [Cell Rep] 2024 Mar 26; Vol. 43 (3), pp. 113924. Date of Electronic Publication: 2024 Mar 18.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [Cambridge, MA] : Cell Press, c 2012-
مواضيع طبية MeSH: Carcinoma, Hepatocellular*/metabolism , Liver Neoplasms*/pathology, Animals ; Humans ; Mice ; Disease Models, Animal ; ELAV-Like Protein 1/metabolism ; RNA/metabolism ; Sumoylation
مستخلص: The posttranslational modification of proteins critically influences many biological processes and is a key mechanism that regulates the function of the RNA-binding protein Hu antigen R (HuR), a hub in liver cancer. Here, we show that HuR is SUMOylated in the tumor sections of patients with hepatocellular carcinoma in contrast to the surrounding tissue, as well as in human cell line and mouse models of the disease. SUMOylation of HuR promotes major cancer hallmarks, namely proliferation and invasion, whereas the absence of HuR SUMOylation results in a senescent phenotype with dysfunctional mitochondria and endoplasmic reticulum. Mechanistically, SUMOylation induces a structural rearrangement of the RNA recognition motifs that modulates HuR binding affinity to its target RNAs, further modifying the transcriptomic profile toward hepatic tumor progression. Overall, SUMOylation constitutes a mechanism of HuR regulation that could be potentially exploited as a therapeutic strategy for liver cancer.
Competing Interests: Declaration of interests The authors declare no competing interests.
(Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.)
References: Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17466-71. (PMID: 23045645)
Cancer Lett. 2021 Jan 1;496:72-83. (PMID: 33038489)
Mol Cell. 1998 Aug;2(2):233-9. (PMID: 9734360)
Nat Cell Biol. 2008 May;10(5):538-46. (PMID: 18408734)
Clin Cancer Res. 2014 Jun 15;20(12):3118-32. (PMID: 24763612)
EMBO J. 2011 Mar 16;30(6):1040-53. (PMID: 21317874)
Sci Signal. 2014 Apr 29;7(323):rs2. (PMID: 24782567)
Trends Cancer. 2021 Jun;7(6):525-540. (PMID: 33358111)
EMBO Rep. 2014 Aug;15(8):878-85. (PMID: 24891386)
J Cell Biochem. 2020 Jun;121(5-6):3372-3381. (PMID: 31943317)
Biochem Biophys Res Commun. 2020 Feb 5;522(2):525-531. (PMID: 31784083)
Mol Cell Biol. 2000 Nov;20(22):8458-67. (PMID: 11046142)
J Biol Chem. 2006 Jun 9;281(23):15869-77. (PMID: 16608850)
Cell. 2019 Jan 24;176(3):564-580.e19. (PMID: 30580964)
J Comput Chem. 2005 Dec;26(16):1668-88. (PMID: 16200636)
Gut. 2017 Jul;66(7):1286-1296. (PMID: 27849562)
Nat Rev Cancer. 2017 Mar;17(3):184-197. (PMID: 28134258)
Nucleic Acids Res. 2019 Jan 25;47(2):1011-1029. (PMID: 30418581)
Mol Cancer Res. 2015 May;13(5):809-18. (PMID: 25678597)
Mol Cell Biol. 2009 Aug;29(16):4341-51. (PMID: 19528229)
Cell. 2019 Oct 31;179(4):813-827. (PMID: 31675495)
Genome Biol. 2002 Jun 18;3(7):RESEARCH0034. (PMID: 12184808)
Exp Mol Med. 2023 Jan;55(1):132-142. (PMID: 36609600)
J Mol Graph. 1996 Feb;14(1):33-8, 27-8. (PMID: 8744570)
Tumour Biol. 2016 Jun;37(6):7741-8. (PMID: 26695141)
J Biol Chem. 2001 Apr 20;276(16):12654-9. (PMID: 11124955)
Nat Rev Mol Cell Biol. 2022 Nov;23(11):715-731. (PMID: 35750927)
Hepatology. 2012 Apr;55(4):1237-48. (PMID: 22095636)
Cell Death Dis. 2020 Oct 2;11(10):822. (PMID: 33009373)
Hepatology. 2012 Sep;56(3):982-93. (PMID: 22407595)
EMBO J. 1999 Nov 15;18(22):6455-61. (PMID: 10562557)
Mol Biol Cell. 2021 Sep 1;32(19):1849-1866. (PMID: 34232706)
Mol Cell. 2020 Apr 2;78(1):9-29. (PMID: 32243832)
Sci Rep. 2013;3:1690. (PMID: 23604351)
Nat Struct Mol Biol. 2017 Mar;24(3):325-336. (PMID: 28112733)
Circulation. 2019 Jan 2;139(1):101-114. (PMID: 29970364)
J Biol Chem. 2003 Jun 13;278(24):21327-30. (PMID: 12716907)
Genome Biol. 2014;15(12):550. (PMID: 25516281)
Cancer Discov. 2019 Aug;9(8):1124-1141. (PMID: 31186238)
J Chem Theory Comput. 2015 Aug 11;11(8):3696-713. (PMID: 26574453)
Nat Commun. 2018 Jun 25;9(1):2456. (PMID: 29942033)
Nat Chem Biol. 2017 Nov;13(11):1164-1171. (PMID: 28892090)
Nat Metab. 2020 Feb;2(2):132-141. (PMID: 32694690)
Cells. 2021 Jan 17;10(1):. (PMID: 33477333)
J Am Chem Soc. 2009 Jul 8;131(26):9230-8. (PMID: 19518050)
Hepatology. 2018 Feb;67(2):586-599. (PMID: 28646552)
Cell. 2017 Jun 15;169(7):1327-1341.e23. (PMID: 28622513)
Mol Cell. 2007 Feb 23;25(4):543-57. (PMID: 17317627)
J Biol Chem. 1999 Apr 9;274(15):10618-24. (PMID: 10187858)
Aging (Albany NY). 2020 Jan 22;12(2):1563-1576. (PMID: 31969492)
Methods. 1998 Mar;14(3):329-41. (PMID: 9571088)
Front Mol Biosci. 2017 Oct 23;4:71. (PMID: 29109951)
J Cell Biol. 2008 Jan 14;180(1):113-27. (PMID: 18180367)
J Biol Chem. 2000 Mar 3;275(9):6252-8. (PMID: 10692421)
EBioMedicine. 2018 Nov;37:356-365. (PMID: 30446432)
Gut. 2020 Aug;69(8):1472-1482. (PMID: 32001555)
Mol Cell. 2010 Aug 13;39(3):333-45. (PMID: 20705237)
J Mol Biol. 1999 Aug 6;291(1):149-62. (PMID: 10438612)
BMC Mol Biol. 2013 Jul 09;14:15. (PMID: 23837869)
Cell Death Dis. 2019 Nov 4;10(11):830. (PMID: 31685796)
Physiol Rev. 2020 Oct 1;100(4):1599-1619. (PMID: 32666886)
Biochem Biophys Res Commun. 2018 Jul 7;502(1):30-42. (PMID: 29777712)
Mol Cell Proteomics. 2008 Jan;7(1):132-44. (PMID: 17938407)
Eur Biophys J. 2012 Jul;41(7):597-605. (PMID: 22706953)
Bioinformatics. 2015 Nov 1;31(21):3483-91. (PMID: 26142185)
FEBS Open Bio. 2021 Jun;11(6):1771-1784. (PMID: 33989451)
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W325-30. (PMID: 24880689)
Nat Commun. 2019 Mar 8;10(1):1146. (PMID: 30850588)
EMBO Rep. 2011 Feb;12(2):142-8. (PMID: 21252943)
Am J Physiol Cell Physiol. 2016 Aug 1;311(2):C284-96. (PMID: 27335169)
PLoS Biol. 2016 Jan 04;14(1):e1002340. (PMID: 26727152)
Cancer Cell. 2014 Jan 13;25(1):118-31. (PMID: 24434214)
Cell Death Differ. 2021 Feb;28(2):730-747. (PMID: 32929216)
Proc Natl Acad Sci U S A. 2010 Aug 3;107(31):13736-41. (PMID: 20631301)
J Med Chem. 2021 Mar 11;64(5):2501-2520. (PMID: 33631934)
Mol Cell. 2020 Jun 18;78(6):1192-1206.e10. (PMID: 32470318)
Mol Cell Proteomics. 2018 Dec;17(12):2534-2545. (PMID: 30385480)
Gastroenterology. 2010 May;138(5):1943-53. (PMID: 20102719)
Wiley Interdiscip Rev RNA. 2017 Jan;8(1):. (PMID: 27307117)
J Chem Theory Comput. 2013 Jul 9;9(7):3084-95. (PMID: 26583988)
EMBO Mol Med. 2022 Dec 7;14(12):e15343. (PMID: 36278433)
Biomedicines. 2021 Jan 27;9(2):. (PMID: 33513829)
FASEB J. 2021 Dec;35(12):e21991. (PMID: 34758157)
J Biol Chem. 2006 Jun 9;281(23):16117-27. (PMID: 16524884)
Nat Commun. 2018 Dec 4;9(1):5145. (PMID: 30514846)
Dev Cell. 2005 Dec;9(6):769-79. (PMID: 16326389)
Gastroenterology. 2004 Nov;127(5 Suppl 1):S51-5. (PMID: 15508103)
Gut. 2017 Dec;66(12):2149-2159. (PMID: 28258134)
Nat Struct Mol Biol. 2014 Oct;21(10):927-36. (PMID: 25218447)
Cell. 2003 Nov 26;115(5):565-76. (PMID: 14651848)
Proteins. 1998 Feb 1;30(2):144-54. (PMID: 9489922)
Mol Cell. 2010 Aug 27;39(4):641-52. (PMID: 20797634)
Front Mol Biosci. 2021 Apr 27;8:658852. (PMID: 33987205)
Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3203-7. (PMID: 11248056)
Mol Cell. 2018 Aug 2;71(3):409-418. (PMID: 30075142)
Mol Cell Proteomics. 2008 Nov;7(11):2107-22. (PMID: 18565875)
Sci Rep. 2018 Oct 19;8(1):15512. (PMID: 30341374)
Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10037-41. (PMID: 11517324)
EBioMedicine. 2019 Feb;40:406-421. (PMID: 30594553)
Cell Rep. 2021 Jan 26;34(4):108691. (PMID: 33503430)
Mol Ther Oncolytics. 2018 Dec 14;12:112-123. (PMID: 30719501)
Oncogene. 2013 Nov 28;32(48):5481-91. (PMID: 23708653)
Mol Biol Cell. 1996 Apr;7(4):495-504. (PMID: 8730094)
Cancers (Basel). 2022 May 27;14(11):. (PMID: 35681645)
Nat Commun. 2017 Mar 08;8:14632. (PMID: 28272405)
EMBO J. 2009 May 6;28(9):1271-82. (PMID: 19322201)
Acta Crystallogr D Biol Crystallogr. 2013 Mar;69(Pt 3):373-80. (PMID: 23519412)
Nat Protoc. 2016 Dec;11(12):2301-2319. (PMID: 27809316)
J Biol Chem. 2011 Oct 14;286(41):35499-35508. (PMID: 21862584)
Annu Rev Pathol. 2014;9:47-71. (PMID: 23937437)
Pharmacol Res. 2020 May;155:104684. (PMID: 32045667)
Mol Cell. 2006 Feb 3;21(3):349-57. (PMID: 16455490)
Nat Protoc. 2009;4(9):1363-71. (PMID: 19730420)
Biochem Biophys Res Commun. 2005 Nov 18;337(2):517-20. (PMID: 16198310)
J Biol Chem. 2001 Sep 21;276(38):35368-74. (PMID: 11451954)
Front Biosci (Landmark Ed). 2012 Jan 01;17(1):189-205. (PMID: 22201738)
Sci Rep. 2016 May 23;6:26509. (PMID: 27211601)
Bioelectrochemistry. 2009 Nov;77(1):43-52. (PMID: 19616485)
J Cancer Res Clin Oncol. 2011 Mar;137(3):533-41. (PMID: 20502916)
Clin Transl Med. 2022 Nov;12(11):e1102. (PMID: 36419260)
Nat Rev Gastroenterol Hepatol. 2020 Mar;17(3):139-152. (PMID: 31792430)
Nat Rev Mol Cell Biol. 2016 Sep;17(9):581-95. (PMID: 27435506)
Nat Commun. 2017 Feb 27;8:14420. (PMID: 28240261)
Nat Rev Clin Oncol. 2016 Jul;13(7):417-30. (PMID: 27030077)
J Biol Chem. 2004 Aug 6;279(32):33791-8. (PMID: 15175327)
Cell Chem Biol. 2021 Oct 21;28(10):1394-1406.e10. (PMID: 33979648)
Cell Mol Life Sci. 2008 Oct;65(20):3168-81. (PMID: 18581050)
J Mol Graph Model. 2002 Dec;21(3):181-3. (PMID: 12463636)
J Biol Chem. 2002 Nov 22;277(47):44623-30. (PMID: 12237300)
Nat Methods. 2009 May;6(5):359-62. (PMID: 19377485)
Clin Proteomics. 2016 Oct 24;13:28. (PMID: 27799868)
Gastroenterology. 2006 Jul;131(1):223-32. (PMID: 16831604)
In Vivo. 2006 Jan-Feb;20(1):17-23. (PMID: 16433023)
Cancer Cell Int. 2020 Jun 12;20:234. (PMID: 32536822)
Mol Cell. 2010 Apr 23;38(2):191-201. (PMID: 20417598)
Nat Cell Biol. 2008 May;10(5):547-55. (PMID: 18408733)
Proc Natl Acad Sci U S A. 2006 Jan 3;103(1):45-50. (PMID: 16371476)
J Proteome Res. 2015 Jun 5;14(6):2385-97. (PMID: 25869096)
Sci Signal. 2012 Dec 04;5(253):ra88. (PMID: 23211528)
Hepatology. 2021 Oct;74(4):1971-1993. (PMID: 33931882)
Trends Cancer. 2021 Jun;7(6):496-510. (PMID: 33353838)
Adv Drug Deliv Rev. 2022 Feb;181:114088. (PMID: 34942276)
Wiley Interdiscip Rev RNA. 2010 Sep-Oct;1(2):214-29. (PMID: 21935886)
Gastroenterology. 2011 Jan;140(1):286-96. (PMID: 20951138)
J Biol Chem. 2010 Jan 1;285(1):357-64. (PMID: 19875442)
Front Oncol. 2021 Dec 07;11:773045. (PMID: 34950583)
Oncotarget. 2017 Jul 25;8(30):49783-49795. (PMID: 28572537)
J Hepatol. 2020 Feb;72(2):342-352. (PMID: 31954496)
Cytometry A. 2006 Jan;69(1):1-12. (PMID: 16342116)
Cancer Biother Radiopharm. 2013 Apr;28(3):196-200. (PMID: 23461386)
EMBO Rep. 2018 Nov;19(11):. (PMID: 30201799)
Biol Chem. 2013 Apr;394(4):459-69. (PMID: 23362194)
J Vis Exp. 2019 Nov 1;(153):. (PMID: 31736480)
Oncotarget. 2015 Nov 10;6(35):37706-23. (PMID: 26416353)
PLoS One. 2013 Sep 13;8(9):e74248. (PMID: 24058533)
Nat Commun. 2017 Oct 27;8(1):1171. (PMID: 29079793)
Eur Rev Med Pharmacol Sci. 2016 Sep;20(17):3566-73. (PMID: 27649656)
معلومات مُعتمدة: R37 CA230636 United States CA NCI NIH HHS; Z01 AG000511 United States ImNIH Intramural NIH HHS
فهرسة مساهمة: Keywords: CP: Cancer; CP: Molecular biology; ELAVL1; HCC; PTMs; SUMO; senescence
المشرفين على المادة: 0 (ELAV-Like Protein 1)
63231-63-0 (RNA)
0 (Elavl1 protein, mouse)
0 (ELAVL1 protein, human)
تواريخ الأحداث: Date Created: 20240320 Date Completed: 20240401 Latest Revision: 20240425
رمز التحديث: 20240425
مُعرف محوري في PubMed: PMC11025316
DOI: 10.1016/j.celrep.2024.113924
PMID: 38507413
قاعدة البيانات: MEDLINE
الوصف
تدمد:2211-1247
DOI:10.1016/j.celrep.2024.113924